Abbott Opens Fire On J&J Unit Over Humira Patent
Abbott Biotechnology Ltd. has filed a suit alleging a Johnson & Johnson unit's newly approved drug infringes Abbott's patent for the blockbuster rheumatoid arthritis medication Humira....To view the full article, register now.
Already a subscriber? Click here to view full article